One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...
A recent study from Karolinska Institutet suggests that a type of diabetes medication called GLP-1 agonists could reduce the ...
Kennedy Jr. was pressed to clarify his views on vaccines, abortion and public health priorities in the first of two senate ...
Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...
One London clinic has become the first in Europe to offer the drug privately for an 'eye-watering' annual sum, after the NHS ...
Although there are more than 944,000 people in the UK who have dementia and more than 55 million living with the disease ...
The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...
Antimicrobials, vaccines, and anti-inflammatories are associated with a reduced risk for Alzheimer disease and dementia.
A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...
Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...
Xenon is one of the six noble gases. Its name derives from the Greek word for “strange”. In medicine, it has been used as an ...
The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback